Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 10
1949 1
1954 1
1957 1
1963 3
1964 27
1965 418
1966 663
1967 670
1968 729
1969 771
1970 756
1971 744
1972 713
1973 679
1974 700
1975 598
1976 653
1977 631
1978 666
1979 725
1980 742
1981 752
1982 831
1983 963
1984 933
1985 1009
1986 1111
1987 1137
1988 1161
1989 1228
1990 1332
1991 1214
1992 1293
1993 1404
1994 1353
1995 1605
1996 1642
1997 1616
1998 1808
1999 1855
2000 1949
2001 2154
2002 2274
2003 2563
2004 2655
2005 2963
2006 3258
2007 3128
2008 3227
2009 3278
2010 3654
2011 3907
2012 4176
2013 4463
2014 4812
2015 5219
2016 5008
2017 5102
2018 5215
2019 5587
2020 9241
2021 8414
2022 9006
2023 8395
2024 4060

Text availability

Article attribute

Article type

Publication date

Search Results

136,408 results

Results by year

Filters applied: . Clear all
Page 1
Immunomodulatory treatment of interstitial lung disease.
van den Bosch L, Luppi F, Ferrara G, Mura M. van den Bosch L, et al. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221117002. doi: 10.1177/17534666221117002. Ther Adv Respir Dis. 2022. PMID: 35938712 Free PMC article. Review.
State-of-the-art evidence in the treatment of systemic sclerosis.
Pope JE, Denton CP, Johnson SR, Fernandez-Codina A, Hudson M, Nevskaya T. Pope JE, et al. Nat Rev Rheumatol. 2023 Apr;19(4):212-226. doi: 10.1038/s41584-023-00909-5. Epub 2023 Feb 27. Nat Rev Rheumatol. 2023. PMID: 36849541 Free PMC article. Review.
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
Mankikian J, Caille A, Reynaud-Gaubert M, Agier MS, Bermudez J, Bonniaud P, Borie R, Brillet PY, Cadranel J, Court-Fortune I, Crestani B, Debray MP, Gomez E, Gondouin A, Hirschi-Santelmo S, Israel-Biet D, Jouneau S, Juvin K, Leger J, Kerjouan M, Marquette CH, Naccache JM, Nunes H, Plantier L, Prevot G, Quetant S, Traclet J, Valentin V, Uzunhan Y, Wémeau-Stervinou L, Bejan-Angoulvant T, Cottin V, Marchand-Adam S; EVER-ILD investigators and the OrphaLung network. Mankikian J, et al. Eur Respir J. 2023 Jun 8;61(6):2202071. doi: 10.1183/13993003.02071-2022. Print 2023 Jun. Eur Respir J. 2023. PMID: 37230499 Free article. Clinical Trial.
Targeting immunometabolism against acute lung injury.
Ning L, Shishi Z, Bo W, Huiqing L. Ning L, et al. Clin Immunol. 2023 Apr;249:109289. doi: 10.1016/j.clim.2023.109289. Epub 2023 Mar 12. Clin Immunol. 2023. PMID: 36918041 Free PMC article. Review.
Nintedanib in children and adolescents with fibrosing interstitial lung diseases.
Deterding R, Young LR, DeBoer EM, Warburton D, Cunningham S, Schwerk N, Flaherty KR, Brown KK, Dumistracel M, Erhardt E, Bertulis J, Gahlemann M, Stowasser S, Griese M; InPedILD trial investigators. Deterding R, et al. Eur Respir J. 2023 Feb 2;61(2):2201512. doi: 10.1183/13993003.01512-2022. Print 2023 Feb. Eur Respir J. 2023. PMID: 36041751 Free PMC article. Clinical Trial.
Senotherapy for lung diseases.
Barnes PJ. Barnes PJ. Adv Pharmacol. 2023;98:249-271. doi: 10.1016/bs.apha.2023.04.001. Epub 2023 Apr 20. Adv Pharmacol. 2023. PMID: 37524489
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Inoue Y, Richeldi L, Walsh SLF, Kolb M, Koschel D, Moua T, Stowasser S, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Flaherty KR, et al. Eur Respir J. 2022 Mar 17;59(3):2004538. doi: 10.1183/13993003.04538-2020. Print 2022 Mar. Eur Respir J. 2022. PMID: 34475231 Free PMC article. Clinical Trial.
136,408 results
You have reached the last available page of results. Please see the User Guide for more information.